Global leader in the field of clinically proven, innovative medical equipment for health monitoring and therapy. Committed to improving people's lives, OMRON Healthcare provides clinically proven, innovative medical equipment for health monitoring and therapy. With over 300 million blood pressure monitors sold, OMRON Healthcare is market leader in digital blood pressure monitors for both home and professional use. Our product portfolio includes blood pressure monitors, nebulizers, electronic thermometers and activity counters as well as body composition monitors and professional medical devices. For many decades, OMRON’s devices have helped people to prevent, treat and manage lifestyle diseases both at home and …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Empowering precision medicine through advanced diagnosis CENTOGENE is a leading company in the field of genetic diagnostics and precision medicine, dedicated to transforming clinical, genetic, and biochemical data into medical solutions for patients. Based in Rostock, Germany, the company operates globally. Founded in 2006 with the mission of revolutionizing the diagnosis of rare diseases, CENTOGENE has since scaled its capabilities to diagnose more than 2,500 rare diseases in over 100 countries, building one of the largest genetic databases in the world (1,000,000 individuals) while developing cutting-edge technology for the interpretation of genetic data. With over 350 scientific publications, CENTOGENE is …

155 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

SCALEO® Medical conceptualizes, develops and manufactures high-tech CE certified medical devices. Our goal is to build a successful and high technology company in the medical field, providing the best care and effective product solutions for the nursing staff and the patients. SCALEO Medical invents, develops and manufactures innovative products in the fields of patient transfer and hygiene, respiratory and medical weighing equipments. We are committed to helping our patients by developing safer and more effective products for more specialized care. We want to highlight quality products and references that will convince by their efficiency and reliability. We are committed to …

69 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Created in 1986, the Polidis laboratory is a human -sized company that has built its notoriety in the field of medical devices. Its recognized expertise in the universe of condoms also extends to that of pregnancy tests, ovulation tests, anti-pain gels, food supplements as well as in a wide range of anti-poux and slow products (shampoo, treatment cream, bi-phase lotion and slowdown). Its status as a French manufacturer as well as the excellent reputation of its products make the Polidis laboratory a privileged partner of the French pharmacy. Innovation is the key to success. This is why we ask our …

7 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

160 liberal practitioners bringing together many specialties exercise there thanks to a high -level technical infrastructure. In addition, multidisciplinary medical teams ensure, 24 hours a day, security management of hospitalized or emergency patients. 500 health professionals are present on a daily basis with patients. The establishment, organized in different activity centers, offers a full care path that is available through care for both diagnostic, therapeutic and rehabilitation. Medical and interventional cardiology, specialties medicine, specialties surgery, ugenity medicine, diagnosis, perinatality, and follow -up care and rehabilitation

71 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster:​ - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. ​ - We accelerate their Research thanks to our Contract Research Services’ …

102 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. …

Type: SMB Activities: biotech deeptech healthtech cosmetics Technologies: Synthetic Biology

Amsbio is a global supplier of research products and custom services for biological and pharmaceutical research Accelerate your discovery with exceptional service and innovative, cutting-edge life science products Founded over 35 years ago, AMSBIO is a premier life sciences supplier dedicated to meeting diverse research needs. AMSBIO’s product lines are carefully curated with top tier products to give high choice and quality control, as well as offering advanced, flexible and tailored custom services. In addition, AMSBIO’s focus on generally underserved areas, such as Glycobiology, highlights a wider mission to advancing niche fields in life science. AMSBIO is ISO9000 Certified to …

Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Say goodbye to finger pricking! Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

First Biofactoría de Europe aimed at obtaining natural and healthy products, based on biotechnology. Naturae © is a set of ingredients that can be added to all types of food and drinks and that, among other beneficial effects for our health, safely and naturally activate the immune system, enhance cholesterol control and improve cardiovascular circulation. Naturae © is obtained from own and registered strains of natural fungi, such as shiitake or yeast. It is completely free of genetically modified organisms (OGM) and its extraction is carried out naturally, through patented methods, without supply of synthetic substances. Naturae © It fulfills …

Type: Startup Activities: foodtech Technologies: Bio sourced materials Synthetic Biology

Translating condensate biology into medicine. Dewpoint is the first company to apply an emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Novo Nordisk, Evotec and Chemify. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable. Please be aware of the potential …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Solve scale. Change world. A quantum computer harnesses the fundamental forces that govern the physical world. It can efficiently model complex systems in ways that would take the best classical computer millions of years, and so help revolutionise drug design, climate modelling, battery chemistry, and many other vital processes. But to achieve all this, we need to make quantum computers work reliably at scale. We started Universal Quantum to meet this challenge - because we believe that by doing so, we can help solve the most difficult problems faced by humanity. We’re following a pragmatic, engineering-based roadmap to build a …

5 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Leader in the sports nutrition industry empowering people everywhere to realize their potential and achieve their goals. Optimum Nutrition, Inc. (ON) is part of the Glanbia global nutrition group and has been setting the Gold Standard in sports nutrition for more than 30 years - helping performance focused athletes achieve their goals We are the creators of 100% Whey Protein (The Worlds #1 Protein Powder), Gold Whey Standard 100% Casein, Essential Amino Energy, Diet Products, Strength and Recovery Supplements, and other health and nutrition products.

17 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

The Premier Commercialization and Marketing Partner for Orphan Drugs and Rare Disease Markets Worldwide Havas Life Rare brings strategic thinking, creative solutions, and true partnership to the rare disease market. We work with companies throughout the entire lifecycle to develop commercial strategy, meaningful engagement with the patient-clinician-advocacy community, and ensure that the right therapy reaches the right patient. In a setting where natural history, diagnosis, awareness and differentiation are typically underdeveloped, we bring rigorous strategic thinking, deep medical insight, data-driven omnichannel marketing, and extensive rare disease commercial experience to navigate the right path forward.

7 similar entities Type: Startup Activities: healthtech martech Technologies: Synthetic Biology

We develop Medical Device Software for professionals to produce personalized products using AI to automatize the process We want to change the current immobilization methods such as plaster and current orthotic systems, to solve the problems that come from these immobilization systems. The immobilizations are printed with 3D printing technology and suitable for accurate measurements of the patient's anatomy. With Xkelet, the patient can shower and dry without problems, no longer scratching due to scaling of the skin, in case the injury includes a wound already well derived by the fracture itself as an operative process, the patient and the …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Release your next batch faster. AI-powered cloud platform for batch-based manufacturing. Apprentice’s Tempo Manufacturing Cloud is the first AI-powered cloud platform for batch-based manufacturing. Tempo connects your teams, systems, sites, and external partners across one cloud-based platform to provide seamless processing through every layer of your manufacturing ecosystem. By combining historically distributed systems — Manufacturing Execution System (MES), Distributed Control System (DCS), Laboratory Execution System (LES), eLogs, Work Instructions, Tempo optimizes end-to-end manufacturing processes. AI is embedded in every step of the process, driving innovation from design to creation, through to simulation and execution, delivering the power of the next …

7 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Discovery of innovative therapeutic antibodies for human and animal health MabGenesis is a biopharmaceutical startup that delivers first-in-class and best-in-class therapeutic monoclonal antibodies using technologies established by 30+ years of academic research. By using the innovative technology platform, high-quality phage display antibody libraries (MOURA Libraries) and efficient antibody isolation technology (IMPACT), MabGenesis makes it possible to isolate 100% species-specific monoclonal antibodies rapidly and efficiently. MabGenesis is a private company headquartered in Yokohama, Japan. For more information, visit https://mabgenesis.com/en Biotechnology, Antibody, Monoclonal antibody, VHH, membrane protein, Canine, Feline, GPCR, Autoimmune diseases, Cancer, Inflammatory diseases, Phage display antibodies, and Antibodydiscovery

77 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Shaping the future of veterinary medicine through one-time therapies for major chronic pet health conditions. Scout’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine. By combining world-leading talent in animal health and gene therapy technology, we have built a development platform for one-time therapies that address major areas of unmet medical need in pet medicine. We are a global company supported by leading life sciences investors and an R&D collaboration with the renowned Gene Therapy Program at the University of Pennsylvania. About Our Currently Enrolling Study for Cats Scout’s first therapy …

Type: Startup Activities: deeptech biotech pettech Technologies: Synthetic Biology

Our team is committed to supporting their work by supplying innovative poultry vaccines and feed solutions. Our optimal mix of advanced products and unmatched support enable farmers to uphold the highest standards for bird health. We are proud to be a trusted partner, working hard to meet our customers’ individual needs.

42 similar entities Type: Startup Activities: foodtech Technologies: Synthetic Biology

Phibro Animal Health is a leading manufacturer of diverse veterinary preparations and mineral feed additives on the global market, having the headquarters of Teaneck, New Jersey (USA) and numerous offices located around the world. We operate in over 30 countries, supporting the development and achievements of our clients. We are constantly conducting research and development, production and sale of innovative medicinal products, in particular technologically advanced poultry vaccines, which are the main specialization of our company. In 2012, Phibro entered the European market of nutrition products for dairy cattle. Today we offer two main products: Omnigen and Animate, but our …

6 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Best-in-class viral vector and nucleic acid development and manufacturing services Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing …

Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology

Please view our Community Guidelines, https://www.msd-animal-health.co.uk/social-media MSD Animal Health is the global animal health business unit of MSD. Through our commitment to the Science of Healthier Animals®, we offer veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. We are dedicated to preserving and improving the health, welfare and performance of animals and the people who care for them.

42 similar entities Type: Startup Activities: healthtech pettech Technologies: Synthetic Biology

Dogs Saving Lives We train dogs to help the NHS and save lives Medical Detection Dogs works with the powerful scenting ability of dogs. We train them to detect the odour of diseases like cancers, Parkinson’s disease, malaria and potentially fatal bacterial infections, as well helping people with complex, life-threatening medical conditions stay safe and lead more normal, independent lives. Our Medical Alert Assistance Dogs save lives daily by alerting their human partners to an odour change which indicates an oncoming, potentially fatal medical event. Conditions W have trained dogs to alert to include Type 1 diabetes, PoTS, Addison’s disease …

Type: Startup Activities: deeptech healthtech biotech pettech Technologies: Synthetic Biology

Unbound by convention, bound to save lives Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive. Our Culture: At Boundless, you’ll …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Your partner in immunology projects! ImmunXperts a Q2 Solutions Company, your partner for what’s next in assay and biomarker development, advanced laboratory testing, and translational immunology. ImmunXperts brings an unrivaled ability to efficiently develop immunogenicity and immuno-oncology in vitro assays – to address both wanted and unwanted immunity for novel modalities. Immunogenicity Assessment, Immune Academy, Training, Consultancy, immuno-oncology, Cell Therapy, In vitro, assay development, Primary cells, Immunogenicity, and Immunology

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Makex CO.,LTD. Supply the 3D Desktop Printer for 5years experience, CE certificated,near Ningbo and Shanghai port,this is how we keep good quality and competitice prices for global valued customers. ​Our main products​ ​3D Printer​ Use DLP​ tech data suit for​ Jewelry printing with​ Kinds of resin​,create unique pieces of jewelry​ ​quickly and effectiv. With the high precision,low cost,high efficiency and consistent oral date with standardized production can be suit for many dentistry fields,such as Surgical Drill Guides,Orthodontics,Denture base,Removable Die,Night Guard,Dental Crown,Denture & Functioning transition teeth.Models. Also suit for the model,eductation,etc. 3d printer, 3d desktop printer, DLP PRINTER, JEWELRY 3D PRINTING, …

64 similar entities Type: Startup Activities: industry 4.0 Technologies: 3D Printing Synthetic Biology

TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases. TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS). Biotechnology, hematological malignancies, non-Hodgkin's lymphoma, multiple sclerosis, b-cell diseases, ublituximab, and umbralisib

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells'​ fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology …

13 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

in vivo testing at the in vitro scale At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our pioneering Organism-on-Chip platform, SydLabTM One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before. By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward. #inwormwetrust Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. …

184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Together, Re-imagining Gynecology with "Gentle" in Mind. Aspivix is a medical device company in women’s health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, CarevixTM, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. CarevixTM is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. CarevixTM study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics …

126 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences …

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission …

Type: Startup Activities: healthtech deeptech manufacturing biotech Technologies: Affective Computing A.I. Solar Technologies Synthetic Biology Wireless

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

301 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.

Type: Startup Activities: deeptech healthtech smart city Technologies: Synthetic Biology

Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK

83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡ We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed …

Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies. InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Facilitate access to digital by evolving rental You need to finance: & gt; your computer equipment and software, & gt; your video systems, & gt; your communications and telephony equipment, & gt; your medical or laboratory equipment, & gt; your measurement instruments, & gt; your robots and cobots, AGV, AMR, exoskeletons, & gt; your industrial equipment, & gt; your handling machines, & gt; ... Opt for financial rental Digital EASE facilitates business access to technological solutions thanks to evolving rental solutions adapted to user companies as well as solutions. Digital Ease supports solutions providers (manufacturers, distributors, software publishers, integrators, ...) …

Type: Startup Activities: it services Technologies: 3D Printing Robotics Synthetic Biology

Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification

67 similar entities Type: Startup Activities: biotech foodtech Technologies: Synthetic Biology

Platelet-derived Regenerative Therapy for CNS Disorders InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis.

217 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Skin contamination is one of the most probable risks in Nuclear Accidental Exposure with release of radioactivity. In this case whether it is major nuclear or radiological incident in Nuclear Power Plant, a Military submarine base, a Nuclear medicine department or a Dirty Bomb, general public, first responders, workers and soldiers will be exposed and contaminated. The possibility of accidents made the development of new decontamination strategies crucial. Cevidra, Pharmaceutical Laboratory, in collaboration with Institute for Radiological Protection and Nuclear Safety (IRSN-French national public expert in nuclear and radiological risks) is developing, producing and commercializing worldwide the Calixarene Cevidra®, a …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

The reference of health products Act on prevention, optimize and secure your prescriptions, improve patient care. Electronic drug database, artificial intelligence, prevention, diagnostic assistance, and patient care

197 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Technology for Healthcare Medical device

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

CORAL BIOME PHARMA Live cultured corals for Drug discovery Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases. Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity. We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research …

26 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Targeting Beta Cell recovery in Diabetes DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world. Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits. DiogenX is headquartered in Marseille, with labs in Nice (France). Biotechnology and Diabetes

12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing a new class of supraciliary implant for treating glaucoma CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably with a novel design. Founded in 2017 by ophthalmic surgeon and inventor Dr. Philippe Sourdille and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept ‘CID’ is the first implant in the industry to reduce IntraOcular Pressure (IOP) without needing to access the anterior chamber or create a subconjunctival filtration bleb. The device is implanted as a standalone procedure …

7 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families

134 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Alpine arc hepatitis (38,73.74) Prevention and screening for viral hepatitis and liver disease. PROMETHEUS Hepatitis dan l'Arc alpin (Isère, Savoie, Haute Savoie) Health association created in 1999, part of the MRSI. Service for prevention, awareness, screening for viral hepatitis and any other liver disease. Free awareness of audiences at risk or specific, the general public and professionals. Diagnostic orientation prevention and screening permanence (via TROD and FIBROSCAN®) with partners for their audiences. Organization of the day of hepatitis in alpine arc (information of information, screening in collaboration with the analysis laboratory and the CEGIDD, stands, meetings of updating knowledge of …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” …

205 similar entities Type: SMB Activities: consulting govtech healthtech Technologies: Synthetic Biology

Laboratories VIVACY is a French manufacturer specialising in the design, production and distribution of premium injectable medical devices for use in the field of Aesthetic Medicine & Anti-ageing. Founded in 2007 by specialists qualified in biotechnologies and injectable solutions with more than 25 years’ experience in the field, the company has acquired recognised expertise with STYLAGE , a versatile range of patented hyaluronic acid-based dermal fillers and antioxidants, mannitol and sorbitol. The company has also developed injectable medical devices for use in ophthalmology (I.SPACE®), rheumatology (KARTILAGE®) and gynecology (DESIRIAL®). Laboratoires VIVACY is now present in over 80 countries all over …

61 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Innovating vaccines to reduce human diseases. Part of Utrecht Science Park Bilthoven Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials …

7 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leading the way in targeted protein degradation therapeutics Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its PROTAC Discovery Engine to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or metastatic ER+/HER2- …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with …

26 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services

88 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Powering the next wave of genetic medicines through superior delivery ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, and Biotechnology

88 similar entities Type: Startup Activities: deeptech biotech nanotech Technologies: Synthetic Biology

Defy Limits. Deliver Results. Made Scientific is a leading cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy. Since 2019, the company has specialized in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials, and has evolved into an end-to-end clinical-to-commercial service provider. Operating from two U.S.-based manufacturing facilities, Made Scientific combines the flexibility and entrepreneurial spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. CDMO, Process Development, Analytical …

88 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of …

100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Vision for Life: Developing gene therapies and delivery technologies for eye diseases. About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. …

5 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Tackling the toughest cancers. We’re OxSonics, a pioneering clinical-stage therapeutics company committed to developing a ground-breaking platform technology to make anti-cancer drugs smarter, act faster and, above all, work better. Our SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumours. SonoTran® is drug agnostic and requires no drug reformulation enabling its use with both existing and novel therapies. We have our own development programs as well as collaborations with Pharmaceutical and biotech companies to work to bring smarter, faster and better therapies to as many patient groups as possible. Drug Delivery, Oncology, Medical …

81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

On March 2, 2023, Albireo was acquired by Ipsen, strengthening Ipsen’s rare disease portfolio with promising therapeutics for pediatric and adult rare liver diseases. Albireo Pharma is a rare disease company focused on the development of novel bile acid modulators to treat pediatric and adult liver diseases. Albireo’s lead product, Bylvay, was approved by the U.S. FDA as the first drug for the treatment of pruritus in all types of progressive familial intrahepatic cholestasis (PFIC), and in Europe for the treatment of PFIC. Bylvay is also being developed to treat other rare pediatric cholestatic liver diseases with a completed Phase …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a …

6 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

TriSalus Life Sciences® seeks to transform outcomes for patients with solid tumors TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.

138 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures and British Patient Capital.

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical …

36 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Whole-Cell Nano-Tomography SiriusXT has developed and manufactures a soft x-ray microscope (the SXT system), which is marketed primarily to researchers working in disease research and drug discovery. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source. Soft x-ray tomography is essentially a CT scan of the cell, and is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state. The SXT system is used by disease researchers, pharmaceutical companies, bio-technologists and clinicians to aid the understanding of disease pathways, protein-drug interactions …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Delivering Hope to the Heart of our Patients AuriGen Medical are an EUeic supported medical device start up, developing the next generation in left atrial appendage implant technology for the treatment of medication resistant longstanding persistent atrial fibrillation. #EUeic #eicAccelerator

10 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Treating Heart Valve Disease CroíValve is an early-stage medical device company developing a unique transcatheter device to repair the tricuspid valve.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection for women, leveraging the transformative potential of AI and our proprietary biomarker technology. At the heart of this innovation is our GlycoLocate platform, a multi-omics approach powered by tumor marker gangliosides, lipids and proteins. This platform is setting a new gold standard in the quest for life-saving early cancer diagnostics. We are now advancing AKRIVIS GDTM, a cutting-edge liquid biopsy test designed specifically for the early detection of ovarian cancer. Medical Devices, Diagnostics, Prognostics, Biotechnology, Sales, Commercialization, Regulatory, Licensing, Quality, …

57 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Forging a radically new commercial path for scientific discoveries. We license intellectual property from institutions and convert it into products that we manufacture in the Pigtown neighborhood of Baltimore Converting Science into Business, Entrepreneurship, Research, drug design, machine vision, custom materials, and aquaculture technologies

85 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Endocrinology Advisor is an online resource that provides health care professionals with comprehensive information on important principles of care in endocrinology as well as up-to-date clinical news on the diagnosis and treatment of endocrine conditions. Our mission is to offer the most recent clinical research news and evidence-based guidance that will aid health care professionals in the management of endocrine conditions.

3 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

The future of biomonitoring. Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter …

17 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Delivering Success with Confidence

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Advancing ENT Surgery AventaMed is an emerging medical device company focused on simplifying surgical procedures and reducing costs for healthcare providers. AventaMed has developed a novel medical device which allows grommets to be placed safely and quickly in an office setting, eliminating the need for general anaesthetic and costly OR time. 7% of all children have grommets (2 million / year), making it a large market, worth over $5.4 billion worldwide.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Complete whey protein, made more sustainably. We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some …

11 similar entities Type: Startup Activities: agritech biotech deeptech foodtech Technologies: Synthetic Biology

Sealing The Broken Barrier Currently we are not hiring. Please beware of scammers Artus is a pre-clinical stage company developing first-in-class therapeutics for inflammatory and metabolic diseases by targeting barrier dysfunction.

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, we approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Before symptoms present, before irreversible damage is done to the bodies, minds, and lives of patients and families, and before it’s too late —this is where we operate. Our lead investigational product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of clinical type 1 diabetes in at-risk individuals. …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

161 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Enabling Safe and Accurate Infusion Therapy for Anyone, Anywhere Shift Labs is a company dedicated to providing safe, accurate and affordable infusion care to everyone, whether they are receiving care in the home, in an outpatient infusion center, or in an emerging market. Our DripAssist Infusion Monitoring platform is an award-winning solution to monitor gravity IV infusions safely and accurately in any environment. By improving the accuracy of gravity infusions and reducing the side effects caused by common errors in infusion rates and volumes, patients are happier and healthier and nurses are in more control. Our solutions ensures all people …

4 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Advancing Science. Enhancing Vision Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to …

Type: Startup Activities: biotech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

232 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Ecological e-shop with thousands of products tapped in detail. We are melting the composition, testing on each other, packing Zero Waste. EConea - Click in detail For over 10 years we have been taking care of the planet and customers. On virtual shelves we have thousands of products of natural drugstores, cosmetics and healthy snacks that we click on our own, hair, nose and taste. We make the composition to the last letter, we pack the maximum Zero Waste, and yet: ... We do not sew curtains from the peel of potatoes and we do not engage the twigs in …

Type: Startup Activities: retail Technologies: Synthetic Biology

Starting in the mid 1990’s, the founders of Nanovation Partners LLC sponsored research at the University of California at San Diego (UCSD) in the lab of Sungho Jin, PhD. This research showed enhanced osseointegration and reduced implant surface infection by forming thousands of rows of tiny metal oxide nanotubes per square millimeter on the medical implant-to-tissue surface. These nanotubes were formed into the metal oxide surface already present on metal implants. No new materials were formed and no synthetic hydroxyapatite or other coating was needed. The group noticed that nearby stem cells treated the nanotube surfaces more like the outer …

Type: Startup Activities: biotech deeptech manufacturing Technologies: New Materials Synthetic Biology

BariaTek is a clinical stage company dedicated to treating obesity via a reversible non-invasive endoscopic approach. BariaTek Medical is a clinical stage company dedicated to addressing obesity via minimally invasive endoscopic approaches. Obesity is one of the most debilitating pandemics affecting humanity: More than 2 billion people are overweight of which 1 billion suffer from obesity. People suffering from obesity tend to lead shorter, less healthy, lives. Treating overweight-related conditions (diabetes, hypertension, sleep apnea and others) is projected to cost G-20 nations on average 8.7% of their health budgets over the next three decades which is estimated by the United …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Early diagnosis of skin cancers has never been that easy! ONCOMECA is a class IIb medical device according to the EU regulation 2017/745. Our technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 90% reliable technology!

8 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Solutions Personnalisées de Génomique ViroScan3D is a service provider in genomic and micro-genomic located in Lyon. We have ten year experience in genome scale analyses from sample preparation to data analysis. During those years we have developed specific processes dedicated to complex samples (low quality and quantity samples). We propose our services for -Molecular broad spectrum identification of infectious agents, new agents, resistance mutants by whole genome sequencing of viruses and microorganisms (bacteria, yeast, fungi, etc.) -Analysis of complex populations using the metagenome, virome, bacteriome approach to identify the different agents in the population and their proportions -The identification of …

8 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics Synthetic Biology

Intelligent Drug Screening Synens is a French company that manufactures rapid on-site drug screening devices. We strive to deliver reliable and customizable drug test kits and analyzers. At Synens, adaptability is key. We meet the requirements of our clients and the regulations in force. Synens is the designer of the D1 Handheld Analyzer that is used internationally by law enforcement, fire departments, healthcare professionals and in workplaces. Technology, Drug Screening, and Drug of Abuse Detection

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Exploring Cells via Protein Interactions LabSae accelerates in-silico drug design by simulating a real cellular environment via protein interaction networks.

Type: Startup Activities: it services Technologies: Synthetic Biology

Changing lives of neuromuscular patients with gene therapy. Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases. A spin-off of gene therapy pioneer Genethon, Atamyo leverages unique expertise in AAV-based gene therapy and muscular dystrophies from the Progressive Muscular Dystrophies Laboratory at Genethon. Atamyo’s most advanced programs address different forms of limb-girdle muscular dystrophies (LGMD). The name of the company is derived from two words: Celtic Atao which means “Always” or “Forever” and Myo which is the Greek root for muscle. Atamyo conveys the spirit of its commitment to …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovative plant-based products, powered by Tereos. At EnsembleTM Foods, we offer unique and simple plant-based products made primarily from a short list of main ingredients (stock, wheat protein, chickpeas, sunflower oil and potato fiber). We strive to make products from renewable raw materials that are high in protein and fiber and low in saturated fat (contains 5-7g Total Fat per serving). Ensemble's goal is to produce healthy, affordable, plant-based products to support feeding the world. Simply put, our mission is to be "good for you and good for the planet". Ensemble Foods is powered by @tereos , a cooperative of …

Type: Startup Activities: foodtech Technologies: Synthetic Biology

Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation. genomics, synbio, and microbiology

100 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells. LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes - to preserve health and treat inflammatory, infectious and metabolic diseases. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We create ophthalmic therapeutic bio factories to sustainably treat major eye diseases. Eyevensys is a clinical stage, private, biotechnology company developing its innovative EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat a broad range of ophthalmic disease. EyeCET stands for the eye ciliary muscle electro-transfection technology, which uses electroporation to deliver plasmids coding for therapeutic proteins in the eye. EyeCET is safe and non-viral, and it enables the ciliary muscle cells to sustainably produce therapeutic proteins locally. Eyevensys believes its EyeCET technology can improve short and long-term therapeutic outcomes, greatly enhancing patient compliance and significantly …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology